WILLIAM YOUNG: Open Payments
NPI 1649815036 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$90,775 in 313 payments from 22 companies in 2025. Trend: 2023 $1,095 · 2024 $24,196 · 2025 $90,775
Speaker / faculty: $61,742Travel & lodging: $22,173Food & beverage: $6,840Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 149 | $87,777 |
| ABBVIE INC. | 51 | $778 |
| Madrigal Pharmaceuticals | 9 | $300 |
| GENZYME CORPORATION | 11 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $242 |
| Ardelyx, Inc. | 11 | $217 |
| Aimmune Therapeutics, Inc. | 22 | $175 |
| Ipsen Biopharmaceuticals, Inc | 7 | $153 |
| Intercept Pharmaceuticals, Inc. | 7 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $125 |
Products named: TREMFYA, STELARA, DUPIXENT, REZDIFFRA, SKYRIZI, RINVOQ, IBSRELA, ENTYVIO.
Industry payments across SC — which companies pay providers there.
